The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q
about
A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterizationDLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomasThe human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemiaDLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicityRho GTPases in hematopoiesis and hemopathies'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCCStructure of the BH domain from graf and its implications for Rho GTPase recognitionLeukemia-associated Rho guanine nucleotide exchange factor, a Dbl family protein found mutated in leukemia, causes transformation by activation of RhoARAS diseases in childrenDLC1: a significant GAP in the cancer genomeMLL/GRAF fusion in an infant acute monocytic leukemia (AML M5b) with a cytogenetically cryptic ins(5;11)(q31;q23q23).GRAF1a is a brain-specific protein that promotes lipid droplet clustering and growth, and is enriched at lipid droplet junctionsDecreased expression of GRAF1/OPHN-1-L in the X-linked alpha thalassemia mental retardation syndrome.BAR the door: cancer suppression by amphiphysin-like genesEvolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies.GTPase regulator associated with the focal adhesion kinase (GRAF) transcript was down-regulated in patients with myeloid malignanciesMLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomActivation-induced cytidine deaminase accelerates clonal evolution in BCR-ABL1-driven B-cell lineage acute lymphoblastic leukemia.Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes.Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.The human orthologue of CdGAP is a phosphoprotein and a GTPase-activating protein for Cdc42 and Rac1 but not RhoA.Chromosomal bands affected by acute oil exposure and DNA repair errors.ArhGAP9, a novel MAP kinase docking protein, inhibits Erk and p38 activation through WW domain bindingGRAF1 deficiency blunts sarcolemmal injury repair and exacerbates cardiac and skeletal muscle pathology in dystrophin-deficient mice.The biological and clinical significance of MLL abnormalities in haematological malignancies.Molecular classification and pathogenesis of eosinophilic disorders: 2005 update.Stable RNA markers for identification of blood and saliva stains revealed from whole genome expression analysis of time-wise degraded samples.Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndromeCurrent knowledge of the large RhoGAP family of proteins.Myeloid leukemia with t(7;21)(p22;q22) and 5q deletionDual FGF-2 and intergrin alpha5beta1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy.p200 RhoGAP promotes cell proliferation by mediating cross-talk between Ras and Rho signaling pathways.Involvement of Rho GAP GRAF1 in maintenance of epithelial phenotype.Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome.Activation of clg, a novel dbl family guanine nucleotide exchange factor gene, by proviral insertion at evi24, a common integration site in B cell and myeloid leukemias.Graf regulates hematopoiesis through GEEC endocytosis of EGFR.Trisomy 21 with t(5; 11) chromosomal translocation as new unfavorable cytogenetic abnormalities in pediatric acute myeloid leukemia type M2: One case report of nine-year follow-up and literature review.SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23).Acute myeloid leukemiaAcute Myeloid Leukemia
P2860
Q21245233-96832084-6AEA-4C4C-9356-BB53A5B377C8Q23910292-FDB76058-CCEA-4F26-9C92-2BAE29265BBBQ24291407-AA11CD28-23A1-4DEC-8C10-80B46E96403AQ24293186-439C9CFA-E0D0-4DD0-8111-3D0B7C96EE08Q24652636-04B13E96-6C82-4D4D-BD1D-85234711967EQ26786113-2E7C9FFC-8CFA-40CE-9096-ACCFCCE976ECQ27626985-D6C235FF-FD47-4008-AD31-C5DDFA50A84BQ28190494-997D47B9-C7B6-47FC-AADB-284C3798EE70Q28252058-707E57EF-85B9-475F-BB01-1FA340371EC0Q28390592-756574AD-78E8-4DA0-AE5E-4365C89C5B53Q30163820-C59D1485-4176-4EBD-A657-2A635A089116Q30425958-3C09712A-3441-4B5B-AE67-CE73A87015D0Q33625532-CAD361C4-D41E-4C15-88CC-0219978C3D4CQ33870256-E8FB7943-7A58-4623-B2A7-BFD5BBC30C1DQ34028179-425D1B5F-289D-4ED4-A246-059686B866D1Q34081636-F7829DAD-468C-4F41-AABD-80D8CD1500B6Q34136814-C43A2C78-4AAE-43E3-BFFE-63109E2A6D4EQ34168766-DD712038-F8F4-48FC-BFC0-F311AAF63E3CQ34367685-0099B7F3-62AF-421A-A2E8-A5CBA7AA712EQ34405465-3F5178B8-8013-495A-8EBB-F235D08D121CQ34499924-28E57CC0-5E03-4ED1-9F7F-E2891DD4E381Q35058557-B7FC790D-C415-4E6E-8BBD-DC8F4A67F982Q35651832-6CC0284A-C957-46BB-8EFA-D88F73A28560Q35753474-CB6E43ED-85D1-4F72-95EA-B4AB4848C327Q35854955-9413AE2A-BB76-4E5C-A8CF-996BCD9E4E55Q36182741-7180F50B-2649-4991-9E8D-A2778322781AQ36428637-06A9CCD1-5813-4F4D-94CE-590F5F4AF320Q36508959-38854773-1DDC-4D32-A0B6-782FDCEA47A7Q36707513-25883ADD-A0BB-4D8B-8B6C-20D39BB77555Q37260976-7D3D5C39-3475-44BA-B196-8983DD5D8662Q37456497-E2F1F920-9E27-4ECC-BA22-3D81898D0A9DQ38507110-F52DD22A-9164-453B-BEAA-91AE146DE651Q38748555-52B427CD-C8E1-4741-BAD7-567C6142E6ACQ42123629-B0F56129-F573-4D7F-AA49-522BEA45662FQ42818782-FE28B41E-74FA-4BDB-809D-CA9865DC4847Q47586127-3167AD97-3B22-40F3-98F9-35376EF3A3A6Q50067507-22C9ED46-0CAC-4088-9CE3-8A0A534FC87DQ54602756-03AA6053-7CB1-4F9D-9CED-11E2582171F8Q58481761-D9E5384C-882C-4FEB-B9AF-34550D9A3C39Q58481811-A3A572D0-ED59-4946-9BB6-C915A4231947
P2860
The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The human GRAF gene is fused t ...... id leukemia with a deletion 5q
@ast
The human GRAF gene is fused t ...... id leukemia with a deletion 5q
@en
The human GRAF gene is fused t ...... id leukemia with a deletion 5q
@en-gb
The human GRAF gene is fused t ...... id leukemia with a deletion 5q
@nl
type
label
The human GRAF gene is fused t ...... id leukemia with a deletion 5q
@ast
The human GRAF gene is fused t ...... id leukemia with a deletion 5q
@en
The human GRAF gene is fused t ...... id leukemia with a deletion 5q
@en-gb
The human GRAF gene is fused t ...... id leukemia with a deletion 5q
@nl
prefLabel
The human GRAF gene is fused t ...... id leukemia with a deletion 5q
@ast
The human GRAF gene is fused t ...... id leukemia with a deletion 5q
@en
The human GRAF gene is fused t ...... id leukemia with a deletion 5q
@en-gb
The human GRAF gene is fused t ...... id leukemia with a deletion 5q
@nl
P2093
P2860
P921
P356
P1476
The human GRAF gene is fused t ...... id leukemia with a deletion 5q
@en
P2093
A Borkhardt
D Bartelheimer
I F Loncarevic
P2860
P304
P356
10.1073/PNAS.150079597
P407
P577
2000-08-01T00:00:00Z